Navigation Links
Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show

ing used to design clinical studies that have the potential to demonstrate the advantages of the VLP flu vaccines in humans."

About Novavax Inc.

Novavax Inc. is committed to leading the global fight against infectious disease by creating novel, highly potent vaccines that are safer and more effective than current preventive options. Using the company's proprietary virus-like particle (VLP) and Novasome(R) adjuvant technologies, Novavax is developing vaccines to protect against H5N1 pandemic influenza, seasonal flu and other viral diseases. Novavax's particulate vaccines closely match disease-causing viruses while lacking the genetic material to cause disease, which provides potential for greater immune protection at lower doses than current vaccines. With an exclusive portable manufacturing system that allows for rapid mass-production of vaccines, Novavax is uniquely positioned to meet global public health needs.

Forward-Looking Statements

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding clinical developments, safety, efficacy and potency of our vaccines, and supply availability are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the failure by Novavax to secure and maintain relationships with collaborators; risks relating to the early stage of Novavax's product candidates under development; uncertainties relating to commencing clinical trials and their outcome; risks relating to the supply and commercialization, if any, of Novavax's proposed produc
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Novavax Reports Positive Pre-Clinical Study Results from Live Virus Challenge to Pandemic Flu Vaccine
2. Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show
3. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
4. Rapid Response was Crucial to Containing the 1918 Flu Pandemic
5. Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
8. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
9. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
10. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
11. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
Post Your Comments:
(Date:12/19/2014)... 18, 2014 Capnia, Inc. (NASDAQ: ... medical diagnostics based on its proprietary Sensalyze™ Technology ... announced financial results for the third quarter and ... "Following the completion of our initial public offering ... the recently initiated CoSense® commercial launch," said Anish ...
(Date:12/19/2014)... Dec. 18, 2014   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization ... positive results from its pivotal field study of ... pain in dogs with osteoarthritis.  In the study, ... scores that were statistically significant compared to placebo ...
(Date:12/17/2014)... Alemania, December 17, 2014 Los ... con un alto nivel de gasto en investigación y ... 2013/14 (finalizado el 30 de septiembre de 2014) ZEISS ... 4.287 millones de euros (año anterior: 4.190 millones de ... desfavorables. Las ganancias (EBIT) crecieron un 14 por ciento, ...
Breaking Medicine Technology:Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5ZEISS confirma su posición en un entorno difícil 2
... 22, 2012  Argon Medical Devices, Inc. announced today ... catheter, licensed from Rex Medical, LP, designed to ... treatments. "UltraStream provides clinicians with an ... life for their patients," commented George Leondis, President ...
...  Dune Medical Devices, the manufacturer of the MarginProbe ® ... experts in the field of breast cancer regarding the ... the importance of margin assessment in breast conserving surgery. ... with the MarginProbe System, designed to improve a surgeon,s ...
Cached Medicine Technology:Argon Medical Devices Announces The Launch of a Unique New Chronic Hemodialysis Catheter 2Dune Medical Devices Hosts Symposium Featuring MarginProbe® System at European Breast Cancer Conference 2Dune Medical Devices Hosts Symposium Featuring MarginProbe® System at European Breast Cancer Conference 3
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, ... States -- along with Angelina Jolie,s chickenpox and the ... in the nation,s public health defense against infectious disease, ... Half of U.S. states are poorly prepared to ... was the main conclusion of the report issued jointly ...
(Date:12/19/2014)... Hands On Mobile Spa, has announced they now have a ... been transformed into a utopia for the Long Island community ... The Virtual Tour showcases the beauty of the Spa On ... more. , The Virtual Tour shows viewers each of the ... overhauled Winnebago. Marla Kaplan-Pelle, Director states " It's hard to ...
(Date:12/19/2014)... After a 13-year absence from active touring, the ... stage to entertain his many worldwide fans. Trisha Yearwood ... successful tour has been steadily expanding since the very ... Ticketability.com for a large inventory of Garth Brooks ... , Music fans have had a long wait for ...
(Date:12/19/2014)... new study suggests a possible link between certain menopause ... sweats -- and higher rates of hip fractures and ... affecting about 60 percent of women. The hormonal changes ... then face a higher risk of weakened bones and ... or severe menopausal symptoms are more likely to have ...
(Date:12/19/2014)... (HealthDay News) -- Prostaglandin analogue eye drops -- a ... risk of vision loss in patients with the eye ... by David Garway-Heath, of the Moorfields Eye Hospital and ... more than 500 people newly diagnosed with open-angle glaucoma ... one of the leading causes of blindness. About ...
Breaking Medicine News(10 mins):Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2
... effective in differentiating the blood supply to medial and lateral ... according to a study conducted by researchers at the University ... in Petah Tikva, Israel. , Blood supply of medial ... tumors may be supplied by both the internal or lateral ...
... evaluating and diagnosing small bowel disorders is an effective ... to a recent study conducted by researchers at the ... India. Sonoenteroclysis is a new way of doing ... nasojejunal tube in order to alleviate gas in the ...
... PET/CT can help spare patients with clinically operable cervical ... not lead to increased survival of these patients, a ... to determine the value of pretreatment imaging in the ... MD, MPH, of Massachusetts General Hospital in Boston, and ...
... used to measure cardiac function and has the potential ... a preliminary study indicates. , CT coronary angiography provides ... however, CT coronary angiography uses a high radiation dose ... examinations, can evaluate structure and function with no or ...
... Although guidelines keep changing regarding screening mammography in elderly ... benefit from this exam, showing that with frequent mammograms ... recent study conducted by researchers at Jacobi Medical Center ... , Our initial interest was sparked by the ...
... how red blood cell production is controlled could lead ... anaemia, according to West Australian medical researchers. , The ... the journal of the American Society of Hematology and ... Australian scientists, led by Western Australian Institute for Medical ...
Cached Medicine News:Health News:New procedure in diagnosing small bowel disorders proves efficient and effective 2Health News:Screening mammography in elderly patients beneficial 2Health News:Twin findings raise hopes of improved anemia treatments 2
... The QC Manager Point-of-Care Data Management System ... Blood Glucose Testing System and the Precision ... simple, automated way to collect, analyze, and ... format. It provides an essential laboratory tool ...
... The CELL-DYN SMS consistently produces high-quality blood ... consistent blood films every time, eliminating the ... significantly high or low hematocrit values. In ... mixes, identifies the sample, and aspirates only ...
... The QuickVue In-Line Strep A Test allows for ... directly from patient throat swab specimens. , ,QuickVue ... and is the first strep A test waived ... rapid procedure allow testing to take place at ...
... The IntraLase FS laser introduces new ... Surgeons now have the opportunity to ... alternative to a microkeratome for creating the ... IntraLase FS laser and proprietary IntraLASIK software, ...
Medicine Products: